Add to ORKGLack of substantial progress in effective treatment of glioblastomamultiforme has led investigators to explore unconventional treatment options including the use of tumour treating fields and oncolyticvirotherapy. Herein the authors have reviewed some of the recent literature on oncolyticvirotherapy for the treatment of glioblastomamultiforme
Glioblastoma remains essentially incurable, and new therapeutic approaches are urgently needed. Now,...
Glioblastoma (GBM), a WHO grade IV brain tumor, is an aggressive tumor with poor prognosis; even wit...
Central nervous system (CNS) tumors, although rare, represent a group of neoplasms that have a dispr...
IntroductionOncolytic virotherapy is a promising form of gene therapy for cancer, using already exis...
Glial tumors comprise about 60 % of primary malignant brain tumors, and 70 % of them show morphologi...
Glial tumors comprise about 60 % of primary malignant brain tumors, and 70 % of them show morphologi...
To date, no targeted drugs, antibodies or combinations of chemotherapeutics have been demonstrated t...
Currently, standard therapy for GBM consists of tumour resection followed by radiotherapy and concom...
Glioblastoma is in need of innovative treatment approaches. Immune therapy for cancer refers to the ...
AbstractGlioblastoma Multiforme (GBM) is a rapidly progressing brain tumor. Despite the relatively l...
Over the past century, treatment of malignant tumors of the brain has remained a challenge. Refineme...
The prognosis of malignant gliomas remains poor, with median survival fewer than 20 months and a 5-y...
Glioblastoma (GBM) is the most common primary central nervous system tumor in adults. It is a highly...
Glioblastoma Multiforme GBM is a very aggressive type of malignant brain tumors that affects peoples...
Glioblastoma multiforme is the most common and highly aggressive brain tumor, causing high number of...
Glioblastoma remains essentially incurable, and new therapeutic approaches are urgently needed. Now,...
Glioblastoma (GBM), a WHO grade IV brain tumor, is an aggressive tumor with poor prognosis; even wit...
Central nervous system (CNS) tumors, although rare, represent a group of neoplasms that have a dispr...
IntroductionOncolytic virotherapy is a promising form of gene therapy for cancer, using already exis...
Glial tumors comprise about 60 % of primary malignant brain tumors, and 70 % of them show morphologi...
Glial tumors comprise about 60 % of primary malignant brain tumors, and 70 % of them show morphologi...
To date, no targeted drugs, antibodies or combinations of chemotherapeutics have been demonstrated t...
Currently, standard therapy for GBM consists of tumour resection followed by radiotherapy and concom...
Glioblastoma is in need of innovative treatment approaches. Immune therapy for cancer refers to the ...
AbstractGlioblastoma Multiforme (GBM) is a rapidly progressing brain tumor. Despite the relatively l...
Over the past century, treatment of malignant tumors of the brain has remained a challenge. Refineme...
The prognosis of malignant gliomas remains poor, with median survival fewer than 20 months and a 5-y...
Glioblastoma (GBM) is the most common primary central nervous system tumor in adults. It is a highly...
Glioblastoma Multiforme GBM is a very aggressive type of malignant brain tumors that affects peoples...
Glioblastoma multiforme is the most common and highly aggressive brain tumor, causing high number of...
Glioblastoma remains essentially incurable, and new therapeutic approaches are urgently needed. Now,...
Glioblastoma (GBM), a WHO grade IV brain tumor, is an aggressive tumor with poor prognosis; even wit...
Central nervous system (CNS) tumors, although rare, represent a group of neoplasms that have a dispr...